N6-methyladenine demethylase ALKBH1 inhibits the differentiation of skeletal muscle
N6-methyladenine demethylase ALKBH1 inhibits the differentiation of skeletal muscle
复制标题
N6-甲基腺嘌呤去甲基化酶ALKBH1抑制骨骼肌分化
DOI:
10.1016/j.yexcr.2021.112492
复制
发表时间:
2021-02-05
影响因子:
3.7
通讯作者:
Zhang, Qi
中科院分区:
文献类型:
--
作者:
Diao, Li-Ting;Xie, Shu-Juan;Zhang, Qi
DNA N-6-methyladenine (N6-mA) was recently recognized as a new epigenetic modification in mammalian genome, and ALKBH1 was discovered as its demethylase. Knock-out mice studies revealed that ALKBH1 was indispensable for normal embryonic development. However, the function of ALKBH1 in myogenesis is largely unknown. In this study, we found that N6-mA showed a steady increase, going along with a strong decrease of ALKBH1 during skeletal muscle development. Our results also showed that ALKBH1 enhanced proliferation and inhibited differentiation of C2C12 cells. Genome-wide transcriptome analysis and reporter assays further revealed that ALKBH1 accomplished the differentiation inhibiting function by regulating a core set of genes and multiple signaling pathways, including increasing chemokine (C-X-C motif) ligand 14 (CXCL14) and activating ERK signaling. Taken together, our results demonstrated that ALKBH1 is critical for the myogenic differentiation of C2C12 cells, and suggested that N6-mA might be a new epigenetic mechanism for the regulation of myogenesis.